ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,331.69
0.76%
US Tech 100
18,434.00
1.43%
Dow Jones
38,764.34
0.14%
Brent Oil
77.835
0.94%
Bitcoin
71,517.58
1.26%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Reata Pharmaceuticals Inc (RETA)

  7. Reata Pharmaceuticals Inc (RETA) News

RETA

Reata Pharmaceuticals (RETA)

Reata Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RETA
DateTimeSourceHeadlineSymbolCompany
10/06/20234:07PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RETAReata Pharmaceuticals Inc
09/28/20234:30PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RETAReata Pharmaceuticals Inc
09/26/20237:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20235:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:25PMEdgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:23PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:22PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:21PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:19PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:18PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:17PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:16PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:15PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20234:14PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RETAReata Pharmaceuticals Inc
09/26/20238:59AMGlobeNewswire Inc.Biogen Completes Acquisition of Reata PharmaceuticalsNASDAQ:RETAReata Pharmaceuticals Inc
09/21/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RETAReata Pharmaceuticals Inc
09/21/202310:08AMBusiness WireReata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.NASDAQ:RETAReata Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RETA

Your Recent History

TG
FPO
Petra Diamonds
UNSW3
SOLVEETH
Healthcare Administration Token
LSE
50OW
Uruguay 28
BIT
CI1
Amundi Asset Management ...
COIN
ROOBEEGBP
Roobee
AMEX
MOTG
VanEck Morningstar Globa...
TSX
SII
Sprott
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved